The 1st International Symposium What’s New In Pediatrics And Oncology – a...
On 17-18th December, in capital city of Lower Silesia, Wroclaw, an extraordinary scientific event – 1st International Symposium What’s New In Pediatrics And Oncology took place. It was organized by the...
View ArticleTobacco and the cancer treatment – will the eternal enemy become an ally?
Cancer is a common problem that affects people irrespective of race, age or gender. Highly developed countries inhabitants and cigarette smokers are more susceptible to this malady. Oral cancer is the...
View ArticleInhibiting enzyme LOXL2 stops breast cancer progression
During previous experiments it has been established that high activity of enzyme lysyl oxidase (LOX) may be responsible for mammary gland cancer spread. Only recently did it turn out that, blocking...
View ArticleYunzi mushrooms, Abiraterone, Onco-vaccines – new methods against prostate...
Prostate cancer is one of the most commonly appearing cancers. 11% of cancers in men are those linked with prostate neoplasm. The disease begins inconspicuously: frequent difficulties with urination...
View ArticleDoes Helicobacter pylori infection protect against asthma?
Gastric bacterium Helicobacter pylori causes ulcer disease. New results published in the Journal of Clinical Investigation revealed that infection protects against allergy-induced asthma....
View ArticleEnzyme PTPN23 is important regulator of aggressive breast cancer development
Scientists from Cold Spring Harbor Laboratory (CSHL) have identified an enzyme, which is significant regulator of breast cancer development and metastasis. PTPN23 is intracellular protein, which plays...
View ArticleMelanoma – new discovery in fight against it
The fight against melanoma is difficult. The rates are rising dramatically among young people, it is deadly if not caught early and the disease tends to adapt to even the most modern treatment....
View ArticlePeptic ulcers – endoscopy recommendations and new hopes for treatment
A peptic ulcer is a lesion in the gastric or duodenal wall, which broadens through the muscularis mucosa to the submucosal and muscularis propia tissues. Surprisingly it can be more frequently found in...
View ArticleColorectal cancer – a new way to control the efficiency of chemotherapy
German scientists came up with the discovery of a new biomarker which could be controlled to assess a response to chemotherapy of colorectal cancer. Indication of methylation of transcription factor...
View ArticleMetformin in oncology. Popular drug fights cancer.
Metformin is one of the most popular antidiabetic drugs. It is usually well-tolerated and widely used as a first line treatment in type II diabetes. However, there is more to metformin than meets the...
View ArticleBreast cancer – Statins a new perspective in therapy
Statins are one of the world’s most commonly prescribed drugs (1). They are used to lower cholesterol level by inhibiting hydroxy-methylglutaryl-coenzyme A reductase (HMG-CoAR), which is an essential...
View ArticleColorectal cancer – is there an association between blood coagulability and...
Malignant neoplasms change the rheological properties of the blood, leading to a higher risk of thrombosis. Treatment of a cancer also affects the haemostasis. Recent studies carried out in the...
View ArticleLung cancer – new opportunities for the introduction of screening tests
Very important conclusions for the early detection of lung cancer have been included in the recent publication summarizing the U.S. National Lung Screening Trial (NLST). This is the first study in...
View ArticleOsteosarcoma in adults
Osteosarcoma is the most common primary bone tumour. It is characterized by the presence of the fusiform cells producing a malignant extracellular osteoid. Both, the malignancy and the ability to...
View ArticleRemission of malignant melanoma is possible
Scientists from Memorial Sloan Kettering Cancer Center performed a study on one patient, to assess the role of the immune system in the fight against cancer. The results were published in the New...
View ArticleA vaccine for breast cancer
A new vaccine (Neuvax, nelipepimut-S or E75), which can prevent recurrence of early-stage, HER2 medium or low expression breast cancer, is being tested. Currently, since 2011 the vaccine is in a third...
View ArticleThe results of genetic mapping in breast cancer
Breast cancer is one of the most common cancers in women. Since the 70th, until the 90th twentieth century, a steady increase in the incidence of breast cancer could be observed. A breast cancer is now...
View ArticlePD-1 inhibitors in cancer therapy
PD-1 is a receptor which, through a variety of metabolic processes, leads to inactivation of T cells. In the therapy of the cancer, one of the promising new drugs is BMS-936 558, an antibody directed...
View ArticlePhotodynamic therapy in oncology
Photodynamic therapy (called also PDT) is a treatment in which cancer cells previously sensitized to light can be destroyed by the radiation. This method is already used in Japan, USA, Canada,...
View ArticleMicroRNAs in cancer therapy and diagnosis
MicroRNAs are proteins non-coding RNA molecules of about 20-24 nucleotides length. Their function is to control the expression of other genes during transcription or posttranscriptionally. Distinct...
View ArticleWhat could be left in children’s psychic after neoplasm?
The oncologically affected children are only 1 % of the whole oncologic patients. Comforting is the fact that up to 80% of the young patients may recover from neoplasm(1), however, it is widely known...
View Article
More Pages to Explore .....